Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...
China and India, which are the largest producers of APIs for the U.S. drug supply, also account for most of the FDA regulatory actions. Not only do quality problems at Chinese and Indian firms raise ...
Bangladesh, a laggard in the production of raw materials for the $3 billion pharmaceuticals industry, has made a four-fold jump in the manufacturing of active pharmaceutical ingredient (API) in the ...
ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...
Lonza completed a laboratory expansion project at its API manufacturing facility in Nansha, China. The project, which grew the footprint of the lab by 250 square meters, included the addition of new ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Demand for highly potent APIs continues to rise. Highly potent APIs (HPAPIs) are an increasingly important segment of the API market. While there are many contract development and manufacturing ...
In drug development, the active pharmaceutical ingredient (API) is the drug component that provides the health benefits. The purpose of adding APIs is to cause pharmacological activity or direct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results